Previously submitted 1 June 2007: Total number of voting rights and size of share capital in H. Lundbeck A/S as of 1 June 2007

In accordance with Section 17(2) of the Danish Statutory Order on
Issuers' Disclosure Obligations, H. Lundbeck A/S is required on 1
June 2007 to publish the total number of voting rights and the size
of the share capital in H. Lundbeck A/S.

The share capital in H. Lundbeck A/S consists of one class of shares
and as of 1 June 2007 the share capital amounts to DKK 1,063,691,365
divided into 212,738,273 shares of DKK 5 each and 212,738,273 votes.


Lundbeck contacts


Investors:                  Media:

Jacob Tolstrup              Caroline Broge
Investor Relations Manager, Media Relations Manager
North America               +45 36 43 26 38
+1 201 350 0187


                      ________________________

Stock Exchange Release No 275 - 1 June 2007

About Lundbeck
H. Lundbeck A/S is an international pharmaceutical company engaged in
the research and development, production, marketing and sale of drugs
for the treatment of psychiatric and neurological disorders. In 2006,
the company's revenue was DKK 9.2 billion (approximately EUR 1.2
billion or USD 1.6 billion). The number of employees is approximately
5,300 globally. For further information, please visit
www.lundbeck.com